REPLIGEN CORP (RGEN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for RGEN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| RGEN | Executive Vice President and Chief Technical Operations Officer; Director | 61 | ["Risk Oversight", "Finance & Capital Markets", "Manufacturing & Global Operations", "Commercial Sales & Marketing", "30 years of relevant experience", "Senior Vice President, Product and Technology Development at Biogen (2017-2023)", "Vice President of Biopharmaceutical Development at Biogen", "Led a team responsible for cell line, cell culture, purification and device development", "Technical expertise in analytical development and technical services", "Ph.D. in Chemistry from Northeastern University"] | ["Audit"] | 2026 |
Biography sourced from the proxy statement filing.
Member of the Compensation Committee. The Board has determined that Dr. Mhatre is independent within the meaning of the SEC and Nasdaq's director independence standards.